• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

NIH RECOVER Announces $200 Million for Second Round of Clinical Trials

Dakota15

Dakota15

Senior Member
Messages
320
Location
Midwest, USA
Just wanted to share that this morning from the NIH ACD Meeting, Neil Shapiro, NIH Budget Director announced that the RECOVER Initiative has secured an additional $200 million from the pandemic funds [the supplemental appropriations] for a second round of clinical trials in RECOVER [the NIH Initiative tasked with researching Long COVID].

Video embedded below from Twitter / X on announcement.

https://twitter.com/i/web/status/1735325502871626031
 
Last edited:
You must log in or register to reply here.